The Lancet: Published on January, 2023
The appropriate duration of
postoperative antibiotics for complex appendicitis is unclear. The increasing
global threat of antimicrobial resistance warrants restrictive antibiotic use,
which could also reduce side-effects, length of hospital stay, and costs.
TAKE-HOME MESSAGE
This pragmatic, open-label,
randomised controlled trial evaluated whether a 2-day intravenous (IV)
antibiotic course is non-inferior to a 5-day IV antibiotic course after
appendicectomy in patients with complex appendicitis.
The results showed that 2 days of
postoperative IV antibiotics were non-inferior to 5 days of IV antibiotic
course in terms of infectious complications and mortality at 90 days.
These findings apply to laparoscopic appendicectomy conducted in a well-resourced health-care setting suggest that shorter IV antibiotic courses may be acceptable. Adopting this strategy will reduce adverse effects of antibiotics and length of hospital stay.
Background: The
appropriate duration of postoperative antibiotics for complex appendicitis is
unclear. The increasing global threat of antimicrobial resistance warrants
restrictive antibiotic use, which could also reduce side-effects, length of
hospital stay, and costs.
Methods: In this
pragmatic, open-label, non-inferiority trial in 15 hospitals in the Netherlands,
patients with complex appendicitis (aged ≥8 years) were randomly assigned (1:1)
to receive 2 days or 5 days of intravenous antibiotics after appendicectomy.
Randomisation was stratified by centre, and treating physicians and patients
were not masked to treatment allocation. The primary endpoint was a composite
endpoint of infectious complications and mortality within 90 days. The main
outcome was the absolute risk difference (95% CI) in the primary endpoint,
adjusted for age and severity of appendicitis, with a non-inferiority margin of
7·5%. Outcome assessment was based on electronic patient records and a
telephone consultation 90 days after appendicectomy. Efficacy was analysed in
the intention-to-treat and per-protocol populations. Safety outcomes were
analysed in the intention-to-treat population. This trial was registered with
the Netherlands Trial Register, NL5946.
Findings: Between
April 12, 2017, and June 3, 2021, 13 267 patients were screened and 1066 were
randomly assigned, 533 to each group. 31 were excluded from intention-to-treat
analysis of the 2-day group and 30 from the 5-day group owing to errors in
recruitment or consent. Appendicectomy was done laparoscopically in 955 (95%)
of 1005 patients. The telephone follow-up was completed in 664 (66%) of 1005
patients. The primary endpoint occurred in 51 (10%) of 502 patients analysed in
the 2-day group and 41 (8%) of 503 patients analysed in the 5-day group. Rates
of complications and re-interventions were similar between trial groups. Fewer
patients had adverse effects of antibiotics in the 2-day group (45 [9%] of 502
patients) than in the 5-day group (112 [22%] of 503 patients. Re-admission to
hospital was more frequent in the 2-day group (58 [12%] of 502 patients) than
in the 5-day group (29 [6%] of 503 patients. There were no treatment-related
deaths.
Interpretation: 2 days of
postoperative intravenous antibiotics for complex appendicitis is non-inferior
to 5 days in terms of infectious complications and mortality within 90 days,
based on a non-inferiority margin of 7·5%. These findings apply to laparoscopic
appendicectomy conducted in a well-resourced health-care setting. Adopting this
strategy will reduce adverse effects of antibiotics and length of hospital
stay.
Comments
You must login to write comment